nodes	percent_of_prediction	percent_of_DWPC	metapath
Modafinil—CYP2B6—Irinotecan—colon cancer	0.136	0.201	CbGbCtD
Modafinil—CYP2C9—Capecitabine—colon cancer	0.116	0.172	CbGbCtD
Modafinil—CYP3A5—Irinotecan—colon cancer	0.107	0.158	CbGbCtD
Modafinil—CYP3A5—Vincristine—colon cancer	0.0933	0.138	CbGbCtD
Modafinil—CYP1A2—Fluorouracil—colon cancer	0.0763	0.113	CbGbCtD
Modafinil—CYP2C9—Fluorouracil—colon cancer	0.0687	0.102	CbGbCtD
Modafinil—CYP3A4—Irinotecan—colon cancer	0.0416	0.0617	CbGbCtD
Modafinil—CYP3A4—Vincristine—colon cancer	0.0364	0.054	CbGbCtD
Modafinil—Nepafenac—PTGS2—colon cancer	0.00112	0.211	CrCbGaD
Modafinil—Oxaprozin—PTGS2—colon cancer	0.000934	0.176	CrCbGaD
Modafinil—Fenoprofen—PTGS2—colon cancer	0.000772	0.145	CrCbGaD
Modafinil—Discomfort—Irinotecan—colon cancer	0.000697	0.00218	CcSEcCtD
Modafinil—Oedema—Vincristine—colon cancer	0.000695	0.00217	CcSEcCtD
Modafinil—Anaphylactic shock—Vincristine—colon cancer	0.000695	0.00217	CcSEcCtD
Modafinil—Stomatitis—Capecitabine—colon cancer	0.000692	0.00216	CcSEcCtD
Modafinil—Infection—Vincristine—colon cancer	0.00069	0.00216	CcSEcCtD
Modafinil—Urinary tract infection—Capecitabine—colon cancer	0.00069	0.00216	CcSEcCtD
Modafinil—Conjunctivitis—Capecitabine—colon cancer	0.00069	0.00216	CcSEcCtD
Modafinil—Convulsion—Fluorouracil—colon cancer	0.000688	0.00215	CcSEcCtD
Modafinil—Osteoarthritis—Methotrexate—colon cancer	0.000686	0.00214	CcSEcCtD
Modafinil—Confusional state—Irinotecan—colon cancer	0.000682	0.00213	CcSEcCtD
Modafinil—Nervous system disorder—Vincristine—colon cancer	0.000681	0.00213	CcSEcCtD
Modafinil—Haematuria—Capecitabine—colon cancer	0.000677	0.00212	CcSEcCtD
Modafinil—Anaphylactic shock—Irinotecan—colon cancer	0.000677	0.00211	CcSEcCtD
Modafinil—Oedema—Irinotecan—colon cancer	0.000677	0.00211	CcSEcCtD
Modafinil—Myalgia—Fluorouracil—colon cancer	0.000676	0.00211	CcSEcCtD
Modafinil—Chest pain—Fluorouracil—colon cancer	0.000676	0.00211	CcSEcCtD
Modafinil—Infection—Irinotecan—colon cancer	0.000672	0.0021	CcSEcCtD
Modafinil—Hyperhidrosis—Vincristine—colon cancer	0.000672	0.0021	CcSEcCtD
Modafinil—Epistaxis—Capecitabine—colon cancer	0.00067	0.00209	CcSEcCtD
Modafinil—Discomfort—Fluorouracil—colon cancer	0.000668	0.00209	CcSEcCtD
Modafinil—Shock—Irinotecan—colon cancer	0.000666	0.00208	CcSEcCtD
Modafinil—Nervous system disorder—Irinotecan—colon cancer	0.000664	0.00207	CcSEcCtD
Modafinil—Agranulocytosis—Capecitabine—colon cancer	0.000663	0.00207	CcSEcCtD
Modafinil—Anorexia—Vincristine—colon cancer	0.000662	0.00207	CcSEcCtD
Modafinil—Irritability—Methotrexate—colon cancer	0.000655	0.00205	CcSEcCtD
Modafinil—Hyperhidrosis—Irinotecan—colon cancer	0.000654	0.00204	CcSEcCtD
Modafinil—Confusional state—Fluorouracil—colon cancer	0.000653	0.00204	CcSEcCtD
Modafinil—Mood swings—Methotrexate—colon cancer	0.00065	0.00203	CcSEcCtD
Modafinil—Hypotension—Vincristine—colon cancer	0.000649	0.00203	CcSEcCtD
Modafinil—Bradycardia—Capecitabine—colon cancer	0.000649	0.00203	CcSEcCtD
Modafinil—Anaphylactic shock—Fluorouracil—colon cancer	0.000648	0.00202	CcSEcCtD
Modafinil—Oedema—Fluorouracil—colon cancer	0.000648	0.00202	CcSEcCtD
Modafinil—Anorexia—Irinotecan—colon cancer	0.000645	0.00202	CcSEcCtD
Modafinil—Ataxia—Methotrexate—colon cancer	0.000645	0.00201	CcSEcCtD
Modafinil—Infection—Fluorouracil—colon cancer	0.000644	0.00201	CcSEcCtD
Modafinil—Rhinitis—Capecitabine—colon cancer	0.000639	0.002	CcSEcCtD
Modafinil—Nervous system disorder—Fluorouracil—colon cancer	0.000635	0.00199	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Vincristine—colon cancer	0.000633	0.00198	CcSEcCtD
Modafinil—Pharyngitis—Capecitabine—colon cancer	0.000633	0.00198	CcSEcCtD
Modafinil—Tachycardia—Fluorouracil—colon cancer	0.000632	0.00198	CcSEcCtD
Modafinil—Hypotension—Irinotecan—colon cancer	0.000632	0.00198	CcSEcCtD
Modafinil—Urinary tract disorder—Capecitabine—colon cancer	0.000629	0.00197	CcSEcCtD
Modafinil—Insomnia—Vincristine—colon cancer	0.000628	0.00196	CcSEcCtD
Modafinil—Oedema peripheral—Capecitabine—colon cancer	0.000628	0.00196	CcSEcCtD
Modafinil—Connective tissue disorder—Capecitabine—colon cancer	0.000626	0.00196	CcSEcCtD
Modafinil—Urethral disorder—Capecitabine—colon cancer	0.000625	0.00195	CcSEcCtD
Modafinil—Paraesthesia—Vincristine—colon cancer	0.000624	0.00195	CcSEcCtD
Modafinil—Anorexia—Fluorouracil—colon cancer	0.000618	0.00193	CcSEcCtD
Modafinil—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000618	0.00193	CcSEcCtD
Modafinil—Phenylbutazone—PTGS2—colon cancer	0.000617	0.116	CrCbGaD
Modafinil—Visual impairment—Capecitabine—colon cancer	0.000614	0.00192	CcSEcCtD
Modafinil—Insomnia—Irinotecan—colon cancer	0.000612	0.00191	CcSEcCtD
Modafinil—Paraesthesia—Irinotecan—colon cancer	0.000608	0.0019	CcSEcCtD
Modafinil—Hypotension—Fluorouracil—colon cancer	0.000606	0.00189	CcSEcCtD
Modafinil—Decreased appetite—Vincristine—colon cancer	0.000604	0.00189	CcSEcCtD
Modafinil—Dyspnoea—Irinotecan—colon cancer	0.000603	0.00188	CcSEcCtD
Modafinil—Erythema multiforme—Capecitabine—colon cancer	0.000603	0.00188	CcSEcCtD
Modafinil—Somnolence—Irinotecan—colon cancer	0.000601	0.00188	CcSEcCtD
Modafinil—Gastrointestinal disorder—Vincristine—colon cancer	0.0006	0.00187	CcSEcCtD
Modafinil—Fatigue—Vincristine—colon cancer	0.000599	0.00187	CcSEcCtD
Modafinil—Dyspepsia—Irinotecan—colon cancer	0.000596	0.00186	CcSEcCtD
Modafinil—Pain—Vincristine—colon cancer	0.000594	0.00186	CcSEcCtD
Modafinil—Constipation—Vincristine—colon cancer	0.000594	0.00186	CcSEcCtD
Modafinil—Asthma—Methotrexate—colon cancer	0.000593	0.00185	CcSEcCtD
Modafinil—Cardiac disorder—Capecitabine—colon cancer	0.000592	0.00185	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00059	0.00184	CcSEcCtD
Modafinil—Decreased appetite—Irinotecan—colon cancer	0.000588	0.00184	CcSEcCtD
Modafinil—Eosinophilia—Methotrexate—colon cancer	0.000587	0.00183	CcSEcCtD
Modafinil—Insomnia—Fluorouracil—colon cancer	0.000586	0.00183	CcSEcCtD
Modafinil—Gastrointestinal disorder—Irinotecan—colon cancer	0.000584	0.00183	CcSEcCtD
Modafinil—Fatigue—Irinotecan—colon cancer	0.000583	0.00182	CcSEcCtD
Modafinil—Paraesthesia—Fluorouracil—colon cancer	0.000582	0.00182	CcSEcCtD
Modafinil—Constipation—Irinotecan—colon cancer	0.000579	0.00181	CcSEcCtD
Modafinil—Pain—Irinotecan—colon cancer	0.000579	0.00181	CcSEcCtD
Modafinil—Angiopathy—Capecitabine—colon cancer	0.000578	0.00181	CcSEcCtD
Modafinil—Dyspnoea—Fluorouracil—colon cancer	0.000578	0.00181	CcSEcCtD
Modafinil—Somnolence—Fluorouracil—colon cancer	0.000576	0.0018	CcSEcCtD
Modafinil—Immune system disorder—Capecitabine—colon cancer	0.000576	0.0018	CcSEcCtD
Modafinil—Mediastinal disorder—Capecitabine—colon cancer	0.000574	0.00179	CcSEcCtD
Modafinil—Chills—Capecitabine—colon cancer	0.000572	0.00179	CcSEcCtD
Modafinil—Dyspepsia—Fluorouracil—colon cancer	0.00057	0.00178	CcSEcCtD
Modafinil—Arrhythmia—Capecitabine—colon cancer	0.000569	0.00178	CcSEcCtD
Modafinil—Gastrointestinal pain—Vincristine—colon cancer	0.000568	0.00177	CcSEcCtD
Modafinil—Decreased appetite—Fluorouracil—colon cancer	0.000563	0.00176	CcSEcCtD
Modafinil—Pancytopenia—Methotrexate—colon cancer	0.000563	0.00176	CcSEcCtD
Modafinil—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000559	0.00175	CcSEcCtD
Modafinil—Mental disorder—Capecitabine—colon cancer	0.000558	0.00174	CcSEcCtD
Modafinil—Feeling abnormal—Irinotecan—colon cancer	0.000558	0.00174	CcSEcCtD
Modafinil—Malnutrition—Capecitabine—colon cancer	0.000555	0.00173	CcSEcCtD
Modafinil—Pain—Fluorouracil—colon cancer	0.000554	0.00173	CcSEcCtD
Modafinil—Gastrointestinal pain—Irinotecan—colon cancer	0.000553	0.00173	CcSEcCtD
Modafinil—Abdominal pain—Vincristine—colon cancer	0.000549	0.00172	CcSEcCtD
Modafinil—Body temperature increased—Vincristine—colon cancer	0.000549	0.00172	CcSEcCtD
Modafinil—Flatulence—Capecitabine—colon cancer	0.000547	0.00171	CcSEcCtD
Modafinil—Erectile dysfunction—Methotrexate—colon cancer	0.000546	0.00171	CcSEcCtD
Modafinil—Dysgeusia—Capecitabine—colon cancer	0.000543	0.0017	CcSEcCtD
Modafinil—Photosensitivity reaction—Methotrexate—colon cancer	0.000541	0.00169	CcSEcCtD
Modafinil—Back pain—Capecitabine—colon cancer	0.000537	0.00168	CcSEcCtD
Modafinil—Body temperature increased—Irinotecan—colon cancer	0.000535	0.00167	CcSEcCtD
Modafinil—Abdominal pain—Irinotecan—colon cancer	0.000535	0.00167	CcSEcCtD
Modafinil—Feeling abnormal—Fluorouracil—colon cancer	0.000534	0.00167	CcSEcCtD
Modafinil—Muscle spasms—Capecitabine—colon cancer	0.000533	0.00167	CcSEcCtD
Modafinil—Pneumonia—Methotrexate—colon cancer	0.000532	0.00166	CcSEcCtD
Modafinil—Drowsiness—Methotrexate—colon cancer	0.000529	0.00165	CcSEcCtD
Modafinil—Depression—Methotrexate—colon cancer	0.000527	0.00165	CcSEcCtD
Modafinil—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000524	0.00164	CcSEcCtD
Modafinil—Tremor—Capecitabine—colon cancer	0.00052	0.00162	CcSEcCtD
Modafinil—Stomatitis—Methotrexate—colon cancer	0.000515	0.00161	CcSEcCtD
Modafinil—Ill-defined disorder—Capecitabine—colon cancer	0.000515	0.00161	CcSEcCtD
Modafinil—Urticaria—Fluorouracil—colon cancer	0.000515	0.00161	CcSEcCtD
Modafinil—Conjunctivitis—Methotrexate—colon cancer	0.000514	0.00161	CcSEcCtD
Modafinil—Anaemia—Capecitabine—colon cancer	0.000513	0.0016	CcSEcCtD
Modafinil—Body temperature increased—Fluorouracil—colon cancer	0.000512	0.0016	CcSEcCtD
Modafinil—Hypersensitivity—Vincristine—colon cancer	0.000512	0.0016	CcSEcCtD
Modafinil—Sweating—Methotrexate—colon cancer	0.000507	0.00158	CcSEcCtD
Modafinil—Haematuria—Methotrexate—colon cancer	0.000504	0.00157	CcSEcCtD
Modafinil—Malaise—Capecitabine—colon cancer	0.0005	0.00156	CcSEcCtD
Modafinil—Epistaxis—Methotrexate—colon cancer	0.000499	0.00156	CcSEcCtD
Modafinil—Vertigo—Capecitabine—colon cancer	0.000498	0.00156	CcSEcCtD
Modafinil—Hypersensitivity—Irinotecan—colon cancer	0.000498	0.00156	CcSEcCtD
Modafinil—Asthenia—Vincristine—colon cancer	0.000498	0.00156	CcSEcCtD
Modafinil—Syncope—Capecitabine—colon cancer	0.000498	0.00155	CcSEcCtD
Modafinil—Agranulocytosis—Methotrexate—colon cancer	0.000493	0.00154	CcSEcCtD
Modafinil—Palpitations—Capecitabine—colon cancer	0.00049	0.00153	CcSEcCtD
Modafinil—Loss of consciousness—Capecitabine—colon cancer	0.000488	0.00152	CcSEcCtD
Modafinil—Asthenia—Irinotecan—colon cancer	0.000485	0.00152	CcSEcCtD
Modafinil—Cough—Capecitabine—colon cancer	0.000484	0.00151	CcSEcCtD
Modafinil—Hypertension—Capecitabine—colon cancer	0.000479	0.0015	CcSEcCtD
Modafinil—Hypersensitivity—Fluorouracil—colon cancer	0.000477	0.00149	CcSEcCtD
Modafinil—Diarrhoea—Vincristine—colon cancer	0.000475	0.00149	CcSEcCtD
Modafinil—Arthralgia—Capecitabine—colon cancer	0.000472	0.00148	CcSEcCtD
Modafinil—Chest pain—Capecitabine—colon cancer	0.000472	0.00148	CcSEcCtD
Modafinil—Myalgia—Capecitabine—colon cancer	0.000472	0.00148	CcSEcCtD
Modafinil—Pharyngitis—Methotrexate—colon cancer	0.000471	0.00147	CcSEcCtD
Modafinil—Anxiety—Capecitabine—colon cancer	0.000471	0.00147	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000469	0.00147	CcSEcCtD
Modafinil—Urinary tract disorder—Methotrexate—colon cancer	0.000469	0.00146	CcSEcCtD
Modafinil—Discomfort—Capecitabine—colon cancer	0.000467	0.00146	CcSEcCtD
Modafinil—Urethral disorder—Methotrexate—colon cancer	0.000465	0.00145	CcSEcCtD
Modafinil—Diarrhoea—Irinotecan—colon cancer	0.000463	0.00145	CcSEcCtD
Modafinil—Dry mouth—Capecitabine—colon cancer	0.000462	0.00144	CcSEcCtD
Modafinil—Dizziness—Vincristine—colon cancer	0.000459	0.00144	CcSEcCtD
Modafinil—Pruritus—Fluorouracil—colon cancer	0.000458	0.00143	CcSEcCtD
Modafinil—Visual impairment—Methotrexate—colon cancer	0.000457	0.00143	CcSEcCtD
Modafinil—Confusional state—Capecitabine—colon cancer	0.000457	0.00143	CcSEcCtD
Modafinil—Ketoprofen—PTGS2—colon cancer	0.000456	0.0856	CrCbGaD
Modafinil—Oedema—Capecitabine—colon cancer	0.000453	0.00141	CcSEcCtD
Modafinil—Infection—Capecitabine—colon cancer	0.00045	0.00141	CcSEcCtD
Modafinil—Erythema multiforme—Methotrexate—colon cancer	0.000449	0.0014	CcSEcCtD
Modafinil—Dizziness—Irinotecan—colon cancer	0.000447	0.0014	CcSEcCtD
Modafinil—Shock—Capecitabine—colon cancer	0.000446	0.00139	CcSEcCtD
Modafinil—Nervous system disorder—Capecitabine—colon cancer	0.000444	0.00139	CcSEcCtD
Modafinil—Diarrhoea—Fluorouracil—colon cancer	0.000443	0.00139	CcSEcCtD
Modafinil—Tachycardia—Capecitabine—colon cancer	0.000442	0.00138	CcSEcCtD
Modafinil—Vomiting—Vincristine—colon cancer	0.000442	0.00138	CcSEcCtD
Modafinil—Cardiac disorder—Methotrexate—colon cancer	0.00044	0.00138	CcSEcCtD
Modafinil—Skin disorder—Capecitabine—colon cancer	0.00044	0.00137	CcSEcCtD
Modafinil—Rash—Vincristine—colon cancer	0.000438	0.00137	CcSEcCtD
Modafinil—Hyperhidrosis—Capecitabine—colon cancer	0.000438	0.00137	CcSEcCtD
Modafinil—Dermatitis—Vincristine—colon cancer	0.000438	0.00137	CcSEcCtD
Modafinil—Headache—Vincristine—colon cancer	0.000435	0.00136	CcSEcCtD
Modafinil—Anorexia—Capecitabine—colon cancer	0.000432	0.00135	CcSEcCtD
Modafinil—Angiopathy—Methotrexate—colon cancer	0.00043	0.00135	CcSEcCtD
Modafinil—Vomiting—Irinotecan—colon cancer	0.00043	0.00134	CcSEcCtD
Modafinil—Immune system disorder—Methotrexate—colon cancer	0.000429	0.00134	CcSEcCtD
Modafinil—Dizziness—Fluorouracil—colon cancer	0.000429	0.00134	CcSEcCtD
Modafinil—Mediastinal disorder—Methotrexate—colon cancer	0.000428	0.00134	CcSEcCtD
Modafinil—Rash—Irinotecan—colon cancer	0.000427	0.00133	CcSEcCtD
Modafinil—Dermatitis—Irinotecan—colon cancer	0.000426	0.00133	CcSEcCtD
Modafinil—Chills—Methotrexate—colon cancer	0.000426	0.00133	CcSEcCtD
Modafinil—Headache—Irinotecan—colon cancer	0.000424	0.00132	CcSEcCtD
Modafinil—Hypotension—Capecitabine—colon cancer	0.000423	0.00132	CcSEcCtD
Modafinil—Mental disorder—Methotrexate—colon cancer	0.000416	0.0013	CcSEcCtD
Modafinil—Malnutrition—Methotrexate—colon cancer	0.000413	0.00129	CcSEcCtD
Modafinil—Nausea—Vincristine—colon cancer	0.000413	0.00129	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000413	0.00129	CcSEcCtD
Modafinil—Vomiting—Fluorouracil—colon cancer	0.000412	0.00129	CcSEcCtD
Modafinil—Insomnia—Capecitabine—colon cancer	0.00041	0.00128	CcSEcCtD
Modafinil—Rash—Fluorouracil—colon cancer	0.000409	0.00128	CcSEcCtD
Modafinil—Dermatitis—Fluorouracil—colon cancer	0.000408	0.00128	CcSEcCtD
Modafinil—Paraesthesia—Capecitabine—colon cancer	0.000407	0.00127	CcSEcCtD
Modafinil—Headache—Fluorouracil—colon cancer	0.000406	0.00127	CcSEcCtD
Modafinil—Dysgeusia—Methotrexate—colon cancer	0.000404	0.00126	CcSEcCtD
Modafinil—Dyspnoea—Capecitabine—colon cancer	0.000404	0.00126	CcSEcCtD
Modafinil—Fentanyl—ABCB1—colon cancer	0.000402	0.0756	CrCbGaD
Modafinil—Nausea—Irinotecan—colon cancer	0.000402	0.00126	CcSEcCtD
Modafinil—Back pain—Methotrexate—colon cancer	0.0004	0.00125	CcSEcCtD
Modafinil—Dyspepsia—Capecitabine—colon cancer	0.000399	0.00125	CcSEcCtD
Modafinil—Decreased appetite—Capecitabine—colon cancer	0.000394	0.00123	CcSEcCtD
Modafinil—Gastrointestinal disorder—Capecitabine—colon cancer	0.000391	0.00122	CcSEcCtD
Modafinil—Fatigue—Capecitabine—colon cancer	0.00039	0.00122	CcSEcCtD
Modafinil—Pain—Capecitabine—colon cancer	0.000387	0.00121	CcSEcCtD
Modafinil—Constipation—Capecitabine—colon cancer	0.000387	0.00121	CcSEcCtD
Modafinil—Nausea—Fluorouracil—colon cancer	0.000385	0.0012	CcSEcCtD
Modafinil—Ill-defined disorder—Methotrexate—colon cancer	0.000383	0.0012	CcSEcCtD
Modafinil—Anaemia—Methotrexate—colon cancer	0.000382	0.00119	CcSEcCtD
Modafinil—Carbamazepine—ABCB1—colon cancer	0.000375	0.0705	CrCbGaD
Modafinil—Feeling abnormal—Capecitabine—colon cancer	0.000373	0.00117	CcSEcCtD
Modafinil—Malaise—Methotrexate—colon cancer	0.000372	0.00116	CcSEcCtD
Modafinil—Vertigo—Methotrexate—colon cancer	0.000371	0.00116	CcSEcCtD
Modafinil—Gastrointestinal pain—Capecitabine—colon cancer	0.00037	0.00116	CcSEcCtD
Modafinil—Phenytoin—ABCB1—colon cancer	0.000365	0.0685	CrCbGaD
Modafinil—Cough—Methotrexate—colon cancer	0.00036	0.00113	CcSEcCtD
Modafinil—Urticaria—Capecitabine—colon cancer	0.00036	0.00112	CcSEcCtD
Modafinil—Abdominal pain—Capecitabine—colon cancer	0.000358	0.00112	CcSEcCtD
Modafinil—Body temperature increased—Capecitabine—colon cancer	0.000358	0.00112	CcSEcCtD
Modafinil—Convulsion—Methotrexate—colon cancer	0.000358	0.00112	CcSEcCtD
Modafinil—Chest pain—Methotrexate—colon cancer	0.000352	0.0011	CcSEcCtD
Modafinil—Myalgia—Methotrexate—colon cancer	0.000352	0.0011	CcSEcCtD
Modafinil—Arthralgia—Methotrexate—colon cancer	0.000352	0.0011	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000349	0.00109	CcSEcCtD
Modafinil—Discomfort—Methotrexate—colon cancer	0.000347	0.00109	CcSEcCtD
Modafinil—Confusional state—Methotrexate—colon cancer	0.00034	0.00106	CcSEcCtD
Modafinil—Anaphylactic shock—Methotrexate—colon cancer	0.000337	0.00105	CcSEcCtD
Modafinil—Infection—Methotrexate—colon cancer	0.000335	0.00105	CcSEcCtD
Modafinil—Hypersensitivity—Capecitabine—colon cancer	0.000334	0.00104	CcSEcCtD
Modafinil—Nervous system disorder—Methotrexate—colon cancer	0.000331	0.00103	CcSEcCtD
Modafinil—Skin disorder—Methotrexate—colon cancer	0.000327	0.00102	CcSEcCtD
Modafinil—Hyperhidrosis—Methotrexate—colon cancer	0.000326	0.00102	CcSEcCtD
Modafinil—Asthenia—Capecitabine—colon cancer	0.000325	0.00102	CcSEcCtD
Modafinil—Anorexia—Methotrexate—colon cancer	0.000321	0.001	CcSEcCtD
Modafinil—Pruritus—Capecitabine—colon cancer	0.00032	0.001	CcSEcCtD
Modafinil—Hypotension—Methotrexate—colon cancer	0.000315	0.000984	CcSEcCtD
Modafinil—Diarrhoea—Capecitabine—colon cancer	0.00031	0.000968	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000307	0.00096	CcSEcCtD
Modafinil—Insomnia—Methotrexate—colon cancer	0.000305	0.000953	CcSEcCtD
Modafinil—Paraesthesia—Methotrexate—colon cancer	0.000303	0.000946	CcSEcCtD
Modafinil—Dyspnoea—Methotrexate—colon cancer	0.000301	0.000939	CcSEcCtD
Modafinil—Somnolence—Methotrexate—colon cancer	0.0003	0.000936	CcSEcCtD
Modafinil—Dizziness—Capecitabine—colon cancer	0.000299	0.000936	CcSEcCtD
Modafinil—Dyspepsia—Methotrexate—colon cancer	0.000297	0.000927	CcSEcCtD
Modafinil—Decreased appetite—Methotrexate—colon cancer	0.000293	0.000916	CcSEcCtD
Modafinil—Gastrointestinal disorder—Methotrexate—colon cancer	0.000291	0.000909	CcSEcCtD
Modafinil—Fatigue—Methotrexate—colon cancer	0.000291	0.000908	CcSEcCtD
Modafinil—Pain—Methotrexate—colon cancer	0.000288	0.000901	CcSEcCtD
Modafinil—Vomiting—Capecitabine—colon cancer	0.000288	0.0009	CcSEcCtD
Modafinil—Rash—Capecitabine—colon cancer	0.000286	0.000892	CcSEcCtD
Modafinil—Dermatitis—Capecitabine—colon cancer	0.000285	0.000891	CcSEcCtD
Modafinil—Headache—Capecitabine—colon cancer	0.000284	0.000886	CcSEcCtD
Modafinil—Feeling abnormal—Methotrexate—colon cancer	0.000278	0.000868	CcSEcCtD
Modafinil—Methadone—ABCB1—colon cancer	0.000276	0.0518	CrCbGaD
Modafinil—Gastrointestinal pain—Methotrexate—colon cancer	0.000276	0.000861	CcSEcCtD
Modafinil—Nausea—Capecitabine—colon cancer	0.000269	0.00084	CcSEcCtD
Modafinil—Urticaria—Methotrexate—colon cancer	0.000268	0.000837	CcSEcCtD
Modafinil—Body temperature increased—Methotrexate—colon cancer	0.000266	0.000833	CcSEcCtD
Modafinil—Abdominal pain—Methotrexate—colon cancer	0.000266	0.000833	CcSEcCtD
Modafinil—Hypersensitivity—Methotrexate—colon cancer	0.000248	0.000776	CcSEcCtD
Modafinil—Asthenia—Methotrexate—colon cancer	0.000242	0.000756	CcSEcCtD
Modafinil—Pruritus—Methotrexate—colon cancer	0.000238	0.000745	CcSEcCtD
Modafinil—Diarrhoea—Methotrexate—colon cancer	0.000231	0.000721	CcSEcCtD
Modafinil—Dizziness—Methotrexate—colon cancer	0.000223	0.000696	CcSEcCtD
Modafinil—Vomiting—Methotrexate—colon cancer	0.000214	0.00067	CcSEcCtD
Modafinil—Rash—Methotrexate—colon cancer	0.000213	0.000664	CcSEcCtD
Modafinil—Dermatitis—Methotrexate—colon cancer	0.000212	0.000663	CcSEcCtD
Modafinil—Headache—Methotrexate—colon cancer	0.000211	0.00066	CcSEcCtD
Modafinil—Nausea—Methotrexate—colon cancer	0.0002	0.000626	CcSEcCtD
